Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in Patients With Acute Bacterial Skin and Soft Structure Infections from a Phase 2 Randomized, Adaptive-Design, Dose-Ranging Study
Open Forum Infectious Diseases(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要